AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
March 30 (Reuters) - Bioporto A/S:
* BIOPORTO ANNOUNCES ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022
* Q4 ADJUSTED EBITDA LOSS OF DKK 17.9 MILLION
* BECAUSE OF GROUP’S NEED FOR CAPITAL TO IMPLEMENT ITS STRATEGIC INITIATIVES, ACHIEVE HIGHER SALES, NO DIVIDEND IS EXPECTED TO BE PAID IN 2023
* OUTLOOK 2023: ADJUSTED EBITDA LOSS ABOUT DKK (60) TO (65) MILLION
* OUTLOOK 2023: REVENUE AT ABOUT DKK 30 TO 33 MILLION
* PERFORMANCE AND GUIDANCE FOR 2023 ARE DEPENDENT ON CONTINUED RESOLUTION OF COVID-19 PANDEMIC Source text for Eikon: Further company coverage: (Gdansk Newsroom)